FSLBX
Price
$188.78
Change
+$2.13 (+1.14%)
Updated
Jan 17 closing price
Net Assets
1.24B
RYFCX
Price
$71.47
Change
+$0.49 (+0.69%)
Updated
Jan 17 closing price
Net Assets
39.42M
Ad is loading...

FSLBX vs RYFCX

Header iconFSLBX vs RYFCX Comparison
Open Charts FSLBX vs RYFCXBanner chart's image
Fidelity Select Brokerage & Inv Mgmt
Price$188.78
Change+$2.13 (+1.14%)
VolumeN/A
Net Assets1.24B
Rydex Financial Services C
Price$71.47
Change+$0.49 (+0.69%)
VolumeN/A
Net Assets39.42M
FSLBX vs RYFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSLBX vs. RYFCX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSLBX is a Hold and RYFCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FSLBX has more cash in the bank: 1.25B vs. RYFCX (39.4M). FSLBX pays higher dividends than RYFCX: FSLBX (1.12) vs RYFCX (0.00). FSLBX was incepted earlier than RYFCX: FSLBX (40 years) vs RYFCX (24 years). RYFCX is a more actively managed with annual turnover of: 177.00 vs. FSLBX (4.00). FSLBX has a lower initial minimum investment than RYFCX: FSLBX (0) vs RYFCX (2500). FSLBX annual gain was more profitable for investors over the last year : 46.31 vs. RYFCX (29.01). FSLBX return over 5 years is better than : 135.36 vs. RYFCX (15.52).
FSLBXRYFCXFSLBX / RYFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence40 years24 years-
Gain YTD3.9193.265120%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets1.25B39.4M3,160%
Annual Yield % from dividends1.120.00-
Returns for 1 year46.3129.01160%
Returns for 3 years53.88-10.96-492%
Returns for 5 years135.3615.52872%
Returns for 10 years187.7757.03329%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CPOP1.110.05
+4.25%
Pop Culture Group Co Ltd
ASIX31.580.72
+2.33%
AdvanSix
PLX2.220.05
+2.30%
Protalix BioTherapeutics
FOX45.66-0.28
-0.61%
Fox Corp
CERT11.66-0.10
-0.85%
Certara